GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


Principles and methods of benefit-risk assessment in decision-making of medicines


Eu2P Short Course: Principles and methods of benefit-risk assessment in decision-making of medicines

OBJECTIVES

This course gives you an introduction into the principles and methods of comparative Benefit-Risk assessment and their role of benefit-risk assessment in decision-making of medicines.

This course focuses on the different qualitative frameworks and basic quantitative methods for Benefit-Risk assessment, including their potentials and limitations.

BR frameworks, decision-making, transparancy, consistency, objectivity

 

LEARNING OUTCOMES

At the end of the course, you will be able to :

  • Explain definition of benefit and risk in EMA framework
  • Explain the rationale of BR frameworks and quantitative approaches in the process of decision-making (transparency, consistency, objectivity)
  • Distinguish the most important BR frameworks and their key components
  • Describe what BR Modeling and BR profiling is and define differences between these approaches
  • Describe basic methods and outcomes of quantitative BR assessment and present merits and demerits of each approach

 

120 minutes
Online based learning
English language
Certificate of Achievement
200 € / $230
REGISTER NOW

AUTHORS

avatar

Dr. George Quartey

F. Hoffmann-La Roche Ltd

avatar

Nasop Experts Group

ISoP's North American chapter




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 6 30 29 00 29

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners